Tetsuya Mori
About
Tetsuya Mori is a scholar working on Pathology and Forensic Medicine, Public Health, Environmental and Occupational Health and Hematology.
According to data from OpenAlex, Tetsuya Mori has authored 68 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Pathology and Forensic Medicine, 27 papers in Public Health, Environmental and Occupational Health and 19 papers in Hematology. Recurrent topics in Tetsuya Mori's work include Lymphoma Diagnosis and Treatment (39 papers), Acute Lymphoblastic Leukemia research (25 papers) and CNS Lymphoma Diagnosis and Treatment (12 papers). Tetsuya Mori is often cited by papers focused on Lymphoma Diagnosis and Treatment (39 papers), Acute Lymphoblastic Leukemia research (25 papers) and CNS Lymphoma Diagnosis and Treatment (12 papers). Tetsuya Mori collaborates with scholars based in Japan, United States and United Kingdom. Tetsuya Mori's co-authors include Keizo Horibe, Masahito Tsurusawa, Masahiro Sasaki, Setsu Sakamoto, Kazunari Ishii, Mieko Matsui, Ryōji Kobayashi, Akiko Saito, Reiji Fukano and Tetsuo Mitsui and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PEDIATRICS.
In The Last Decade
Tetsuya Mori
64 papers receiving 1.0k citations
Peers
Tetsuya Mori
P Cortinovis-Tourniaire France
P. O’Connor Canada
Hendrik Pels Germany
Hilmar Krapf Germany
Claire Hirst United Kingdom
Benjamin Turner United Kingdom
Shigeru Hoshino Japan
Satkiran S. Grewal United States
Whan Eoh South Korea
Liliana Patrucco Argentina
Citations per year, relative to Tetsuya Mori Tetsuya Mori (= 1×)
peers
P Cortinovis-Tourniaire
Countries citing papers authored by Tetsuya Mori
Since
Specialization
Citations
This map shows the geographic impact of Tetsuya Mori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tetsuya Mori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tetsuya Mori more than expected).
Fields of papers citing papers by Tetsuya Mori
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Tetsuya Mori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tetsuya Mori. The network helps show where Tetsuya Mori may publish in the future.
Co-authorship network of co-authors of Tetsuya Mori
This figure shows the co-authorship network connecting the top 25 collaborators of Tetsuya Mori. A scholar is included among the top collaborators of Tetsuya Mori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tetsuya Mori. Tetsuya Mori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Sekimizu, Masahiro, Reiji Fukano, Yuhki Koga, et al.. (2024). Rituximab-combined anthracycline-free chemotherapy in newly diagnosed paediatric and adolescent patients with non-high-risk aggressive mature B cell lymphoma: protocol for a single-arm, open-label, multicentre, phase II study (the Japan Children’s Cancer Group Multicentre Trial, JPLSG B-NHL-20). BMJ Open. 14(3). e080762–e080762.
2.
Mori, Tetsuya, Tomoo Osumi, Akiko Kada, et al.. (2023). Rituximab with standard LMB chemotherapy in pediatric high‐risk mature B‐cell non‐Hodgkin lymphoma: A report from the JPLSG B‐NHL14 trial. European Journal Of Haematology. 112(4). 585–593.
3.
Takae, Seido, Kimikazu Matsumoto, Masahiro Hirayama, et al.. (2023). Investigation of Fertility Preservation Education Videos for Pediatric Patients Based on International and Historical Survey. Journal of Adolescent and Young Adult Oncology. 12(6). 835–842.
4.
Hara, Junichi, Hiroyuki Shichino, Tatsuo Kuroda, et al.. (2022). Outcome of children with relapsed high-risk neuroblastoma in Japan and analysis of the role of allogeneic hematopoietic stem cell transplantation. Japanese Journal of Clinical Oncology. 52(5). 486–492.
5.
Takae, Seido, Shigeyuki Furuta, Dai Keino, et al.. (2021). Cryopreservation of paediatric ovarian tissue with an updated version of the Edinburgh criteria for appropriate patient selection. Reproductive BioMedicine Online. 44(4). 667–676.
6.
Nakazawa, Atsuko, Masahiro Sekimizu, Tetsuya Mori, et al.. (2021). Clinicopathological features and prognostic significance of programmed death ligand 1 in pediatric ALK-positive anaplastic large cell lymphoma: results of the ALCL99 treatment in Japan. Human Pathology. 116. 112–121.
7.
Fukano, Reiji, Tetsuya Mori, Naoto Fujita, et al.. (2019). Successful outcome with reduced-intensity condition regimen followed by allogeneic hematopoietic stem cell transplantation for relapsed or refractory anaplastic large-cell lymphoma. International Journal of Hematology. 110(6). 723–728.
8.
Sekimizu, Masahiro, Akihiro Iguchi, Tetsuya Mori, et al.. (2018). Phase I clinical study of brentuximab vedotin (SGN-35) involving children with recurrent or refractory CD30-positive Hodgkin’s lymphoma or systemic anaplastic large cell lymphoma: rationale, design and methods of BV-HLALCL study: study protocol. BMC Cancer. 18(1). 122–122.
9.
Iijima‐Yamashita, Yuka, Tetsuya Mori, Atsuko Nakazawa, et al.. (2017). Prognostic impact of minimal disseminated disease and immune response to NPM-ALK in Japanese children with ALK-positive anaplastic large cell lymphoma. International Journal of Hematology. 107(2). 244–250.
10.
Nagai, Hirokazu, Reiji Fukano, Masahiro Sekimizu, et al.. (2017). Phase II trial of CH5424802 (alectinib hydrochloride) for recurrent or refractory ALK-positive anaplastic large cell lymphoma: study protocol for a non-randomized non-controlled trial.. PubMed. 79(3). 407–413.
11.
Sekimizu, Masahiro, Tetsuya Mori, Akira Kikuchi, et al.. (2015). Prognostic impact of cytogenetic abnormalities in children and adolescents with mature B‐cell non‐Hodgkin lymphoma: A report from the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG). Pediatric Blood & Cancer. 62(7). 1294–1296.
12.
Tsurusawa, Masahito, Masahiko Gosho, Tetsuya Mori, et al.. (2014). Statistical analysis of relation between plasma methotrexate concentration and toxicity in high‐dose methotrexate therapy of childhood nonHodgkin lymphoma. Pediatric Blood & Cancer. 62(2). 279–284.
13.
Lin, Mai, David Ranganathan, Tetsuya Mori, et al.. (2012). Long-term evaluation of TiO2-based 68Ge/68Ga generators and optimized automation of [68Ga]DOTATOC radiosynthesis. Applied Radiation and Isotopes. 70(10). 2539–2544.
14.
Sekimizu, Masahiro, Atsuko Nakazawa, Yasuhide Hayashi, et al.. (2011). Chromosome abnormalities in advanced stage T‐cell lymphoblastic lymphoma of children and adolescents: a report from Japanese Paediatric Leukaemia/Lymphoma Study Group (JPLSG) and review of the literature. British Journal of Haematology. 154(5). 612–617.
15.
Fujita, Naoto, Tetsuya Mori, Tetsuo Mitsui, et al.. (2008). The role of hematopoietic stem cell transplantation with relapsed or primary refractory childhood B‐cell non‐Hodgkin lymphoma and mature B‐cell leukemia: A retrospective analysis of enrolled cases in Japan. Pediatric Blood & Cancer. 51(2). 188–192.
16.
Yabe, Hiromasa, Hiroyasu Inoue, Masae Matsumoto, et al.. (2006). Allogeneic haematopoietic cell transplantation from alternative donors with a conditioning regimen of low‐dose irradiation, fludarabine and cyclophosphamide in Fanconi anaemia. British Journal of Haematology. 134(2). 208–212.
17.
Narumi, Satoshi, Hiroyuki Shimada, Noriko Shimasaki, et al.. (2005). Growth‐chart‐based qualitative evaluation of height growth after hematopoietic stem cell transplantation. Pediatric Transplantation. 10(1). 26–31.
18.
Mori, Tetsuya, Kenichi Sugita, Kyoko Kimura, et al.. (2003). Isolated Central Nervous System (CNS) Relapse in a Case of Childhood Systemic Anaplastic Large Cell Lymphoma Without Initial CNS Involvement. Journal of Pediatric Hematology/Oncology. 25(12). 975–977.
19.
Kawashima, Hisashi, Yoshiaki Watanabe, Tsuneo Morishima, et al.. (2003). NOx(Nitrite/Nitrate) in Cerebral Spinal Fluids Obtained from Patients with Influenza-Associated Encephalopathy. Neuropediatrics. 34(3). 137–140.
20.
Sakamoto, Setsu, Kazunari Ishii, Masahiro Sasaki, et al.. (2002). Differences in cerebral metabolic impairment between early and late onset types of Alzheimer's disease. Journal of the Neurological Sciences. 200(1-2). 27–32.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by P Cortinovis-Tourniaire Breakdown of academic impact, for papers by P. O’Connor Breakdown of academic impact, for papers by Hendrik Pels Breakdown of academic impact, for papers by Hilmar Krapf Breakdown of academic impact, for papers by Claire Hirst Breakdown of academic impact, for papers by Benjamin Turner Breakdown of academic impact, for papers by Shigeru Hoshino Breakdown of academic impact, for papers by Satkiran S. Grewal Breakdown of academic impact, for papers by Whan Eoh Breakdown of academic impact, for papers by Liliana Patrucco